Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $964.30M.
ENTERPRISE VALUE (EV)
$964.30M
Ironwood Pharmaceuticals, Inc.
Market Cap
$595.08M
Enterprise Value (EV)
$964.30M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | $595.08M | $964.30M |
| Fulgent Genetics, Inc. (FLGT)vs › | $603.91M | $587.03M |
| OrthoPediatrics Corp. (KIDS)vs › | $581.51M | $656.10M |
| AngioDynamics, Inc. (ANGO)vs › | $611.51M | $557.65M |
| ArriVent BioPharma, Inc. (AVBP)vs › | $569.61M | $415.28M |
| Climb Bio, Inc. (CLYM)vs › | $624.74M | $581.95M |
| CorMedix Inc. (CRMD)vs › | $562.50M | $450.96M |
| Aquestive Therapeutics, Inc. (AQST)vs › | $562.09M | $522.60M |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $633.55M | $582.31M |
Market Cap
$595.08M
Total Debt
$584.68M
Cash
$215.46M
Enterprise Value
$964.30M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
